Japanese Attitudes towards Truth Disclosure in Cancer

Abstract

Despite the increasing concerns of truth disclosure, most cancer patients are not told the truth about their disease in Japan. The author has tried to provide some insight into this issue by evaluating results from questionnaires given to hospital patients, clients in a mass cancer survey, and doctors of a college hospital. Results showed that 72% of patients and 83% of clients wanted to be told the truth, but only 33% and 34% of them thought that the truth should be told to cancer patients. These attitudes of patients and clients regarding truth disclosure were more positive than those of the general public and health care workers in previous studies. At present, 13% of doctors inform cancer patients of their disease. These trends indicate that the Japanese attitude toward avoiding truth disclosure stems primarily from paternalism but is also influenced by social characteristics including insufficient understanding of this issue. Open discussion involving all factions of society is necessary to attain a better understanding of this issue and to promote eventual truth disclosure.

Keywords

truth disclosure informed consent cancer patient's rights Japan

Get full access to this article

View all access options for this article.

References

1. Novack D.H. , Plumer R , Smith RL , Ochitill H , Morrow GR , Benneti JM. Changes in physicians' attitudes toward telling the cancer patient. JAMA 241: 897–900, 1979.

2. Good MJV , Good BJ , Schaffer C , Lind SE. American oncology and the discourse on hope. Cult Med Psychiatry 14: 59–79, 1990.

3. Again thinking of cancer. Scope 26: 3–31, 1987. (In Japanese).

4. Thomsen OS. , WulffHR , Martin A , Singer PA.

What do gastroenterologists in Europe tell cancer patients?

Lancet 341: 473–476, 1993.

5. Long S.O. , Long BD. Curable cancers and fatal ulcers. Attitudes toward cancer in Japan. Soc Sci Med 16: 2101–2108, 1982.

6. Lock M , Honde C. Reaching consensus about death: heart transplantation and cultural identity in Japan. Social Science Perspectives on Medical Ethics, Culture, Illness, and Healing 16: 99–119, 1990.

7. Igata A. Problems in brain death. Nippon Ishikai Zasshi 105: 1073–1077, 1993. (In Japanese).

8. Nudeshima J. Obstacles to brain death and organ transplantation in Japan. Lancet 338: 1063–1064, 1991.

9. Maruyama K , Mizuno H , Yamanouchi T , et al. Should we inform the truth to cancer patients? [Abstracts of panel discussion] Nippon Gann Chiryo Gakkai Shi 5: 107–115, 1970. (In Japanese).

10.

10. Kurita H , Onodera Y.

Should we tell the truth to cancer patients?

Approach from the degree of cognition in terminally ill patients. Kosei No Shihyo 23: 9–16, 1976. (In Japanese).

11.

11. Morioka Y. Informed consent and truth telling to cancer patients. Gastroenterol Jpn 26: 789–792, 1991.

12.

12. Taniguchi M , Hayakawa M , Naito K , Yoshimori M. Patients' wishes towards truth disclosure in cancer. Results from questionnaire to endoscoped clients. Kangogaku Zasshi 47: 1157–1159, 1983. (In Japanese).

13.

13. Takahashi H. Questionnaire study on truth disclosure in cancer. Gendai Igaku 35: 373–376, 1987. (In Japanese).

14.

14. Kojima D. A survey on informed consent. Approach to cancer treatment. Nippon Ika Daigaku Zasshi 58: 39–49, 1991. (In Japanese).

15.

15. Ohara K, Suzuki Y, Suzuki Y, Hunakoshi A. Questionnaire survey on cancer and death. Comparison among doctors, nurses and general public. Nippon Iji Shinpo, No. 3050: 43–50, 1982. (In Japanese).

16.

16. Tsukada K , Suga R , Morita M , et al. A questionnaire on the terminal care and cancer tell in Niigata District. Kenritsu Gansentah Niigata Byoin Ishi 29: 39–46, 1990. (In Japanese).

17.

17. Shirakusa T , Ushijima S , Sasaki H. Survey on truth disclosure in cancer. Fukuoka Daigaku Igaku Kiyo 17: 383–390, 1990. (In Japanese).

18.

18. The Ministry of Health and Welfare and the Japan Medical Association. Manual for terminal care of cancer patients. Nippon Ishikai Zasshi 102 (Suppl. booklet), 1989. (In Japanese).

19.

19. The Bioethics Council of the Japan Medical Association. Report on “setsumei to doi”. Nippon lji Shinpo, No. 3430: 109–112, No. 3431: 112–113, No. 3432: 118–119, 1990. (In Japanese).

20.

20. Tanida N. Patients' rights in Japan [Letter]. Lancet 337: 242–243, 1991.

21.

21. Shouldn't we tell the truth to cancer patients? Nikkei Medical No. 8: 42–52, 1980. (In Japanese).

22.

22. Thinking of cancer. Scope 20: 6–28, 1981. (In Japanese).

23.

23. Radovsky SS. Bearing the news. N Engl J Med 313: 586–588, 1985.

24.

24. Takaku F. Information and consent in medicine. Asia Med J 32: 667–671, 1989.

25.

25. Ikegami N. Japanese health care: low cost through regulated fees. Health Aff 10: 87–109, 1991.

26.

26. Samp R.J. , Curreri AR. A questionnaire survey on public cancer education obtained from cancer patients and their families. Cancer 10: 382–384, 1957.

27.

27. Perry C.B. , Applegate WB. Medical paternalism and patient self-determination. J Am Geriatr Soc 33: 353–359, 1985.